Coagulation Factor-Targeting to TLT-1 on Activated Platelets
a coagulation factor and activated platelet technology, applied in the field of procoagulant proteins and polynucleotides, can solve the problems of threatening bleeding, spontaneous bleeds, and dysfunctional coagulation cascade steps
Inactive Publication Date: 2016-09-15
NOVO NORDISK HEALTH CARE AG
View PDF0 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
In subjects with a coagulopathy, such as human beings with haemophilia A, B or C, various steps of the coagulation cascade are rendered dysfunctional due to, for example, the absence or insufficient presence of a functional coagulation factor.
Such dysfunction of one part of coagulation results in insufficient blood coagulation leading to spontaneous bleeds e.g. in joints and potentially life-threatening bleeding.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
embodiment 1
[0361]A procoagulant protein comprising (i) at least one coagulation factor, covalently attached to (ii) an antibody, or fragment thereof, that is capable of binding (iii) TLT-1, and / or a fragment or variant thereof.
embodiment 2
[0362]The procoagulant protein according to embodiment 1, wherein (iii) is TLT-1, or a fragment or variant thereof.
embodiment 3
[0363]The procoagulant protein according to embodiment 2, wherein (iii) is TLT-1 (16-162).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
molecular weight | aaaaa | aaaaa |
polydispersity index | aaaaa | aaaaa |
Login to View More
Abstract
The current invention relates to: procoagulant proteins which may, for example, be fusion proteins or chemical conjugates; methods of producing said procoagulant proteins; polynucleotides that encode said fusion proteins and cells that expresses them. Furthermore, the current invention relates to procoagulant proteins for use as a medicament. Individuals that have a coagulopathy, such as haemophilia A and B with or without inhibitors, may be treated with the procoagulant proteins of the current invention.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 13 / 982,360 filed Jul. 29, 2013 which is a 35 U.S.C. §371 National Stage application of International Application PCT / EP2012 / 053619 (WO 2012 / 117091 A1), filed Mar. 2, 2012, which claimed priority of European Patent Application 11156682.4, filed Mar. 2, 2011; this application claims priority under 35 U.S.C. §119 of U.S. Provisional Application 61 / 449,254; filed Mar. 4, 2011; the contents of all above-mentioned applications are incorporated herein by reference.FIELD OF THE INVENTION[0002]The current invention relates to procoagulant proteins, polynucleotides that encode procoagulant fusion proteins, cells that express procoagulant fusion proteins, a process for preparing procoagulant proteins and uses of said procoagulant proteins.INCORPORATION-BY-REFERENCE OF THE SEQUENCE LISTING[0003]In accordance with 37 C.F.R. §1.52(e)(5), Applicants enclose herewith the Sequence Listing for...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K47/48C12N9/96C12N9/64C07K16/28A61K38/48
CPCA61K47/4843C07K2319/21A61K38/4846A61K47/48561C12N9/6437C12N9/96C12Y304/21021C07K2317/55C07K2317/24C07K2317/21C07K2317/92C07K2317/41C07K2317/56C07K2317/51C07K2317/515C07K2319/00C07K16/2803C07K2299/00C07K2317/34A61K38/00C07K14/4703C12Y304/21022C12N9/644C07K14/745A61K47/6815A61K47/6849A61P7/04A61K38/36
Inventor HILDEN, IDAPESCHKE, BERNDBREINHOLT, JENSKOFOD-HANSEN, MIKAEL
Owner NOVO NORDISK HEALTH CARE AG
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com